NTNX Nutanix, Inc. Insider Trading

Tarkan Maner (President and CCO) sold 49,259 shares for $2,666,778.25 across 2 transactions; holdings reduced 47.2% to 55,065 shares

Tarkan Maner, President and Chief Compliance Officer, executed two separate sales totaling 49,259 shares for $2,666,778.25 (blended average $54.14) on 2026-05-29 and 2026-06-01. This represents a substantial reduction of 49,259 shares (-47.2% vs pre-transaction holdings), bringing his post-transaction stake to 55,065 shares. The sales occurred while the stock trades at $55.49 current price against a 52-week high of $82.42 (-32.7% from peak), though the company shows solid fundamentals with $703.1M latest-quarter revenue, $72.1M net income, and +18.1% annual revenue growth. The execution of two sales within 3 calendar days at prices near current market levels warrants investor attention given the magnitude of the reduction in this executive's holdings.

Nutanix CEO Rajiv Ramaswami sells 144,707 shares for $11,059,200.69 under pre-arranged 10b5-1 plan

On 2025-10-02, Rajiv Ramaswami, President and CEO of Nutanix Inc., executed 2 separate sales totaling 144,707 shares for $11,059,200.69 at a blended average price of $76.42. This transaction reduces his holdings from 669,315 shares to 524,608 shares, a reduction of 21.6% of pre-transaction holdings. The sales were conducted under a pre-arranged 10b5-1 trading plan adopted on 2025-07-03, making this a scheduled transaction rather than a discretionary trade. This is a material reduction in CEO equity ownership executed through a pre-established plan.

Chief Legal Officer Martin Brian sold 10,241 shares of NTNX at $76.53 on 2025-09-30 under 10b5-1 plan.

Martin Brian, Chief Legal Officer of Nutanix, sold 10,241 shares for a total value of $783,731.44 at $76.53 per share on 2025-09-30. This transaction reduced his holdings by 66.5%, from 15,407 shares to 5,166 shares post-transaction. The sale was executed under a 10b5-1 trading plan adopted on 2025-07-01, meaning it was pre-arranged and scheduled rather than a discretionary trade decision. Since this is a scheduled disposition under a pre-established plan, the timing reflects the plan's mechanics rather than a real-time judgment about the stock's direction, and the transaction should be evaluated in that context.

CFO Sivaraman Rukmini sold 11,391 shares of NTNX at $78.34 for $892,414.23 on 2025-09-16; stock now at $77.66

CFO Sivaraman Rukmini sold 11,391 shares at $78.34, reducing holdings by 4.3% from 266,028 to 254,637 shares. His prior NTNX trades show a timing pattern of 0 well-timed sells at the 90-day mark, with an average 90-day return of +8.8% after his sales—indicating he consistently missed subsequent gains rather than avoiding declines. Currently the stock trades at $77.66, down 6.5% from its 52-week high of $83.07, though up 11.8% over the past 30 days. Nutanix's fundamentals show a company that is unprofitable on a full-year basis despite 15.4% annual revenue growth, with a notably elevated P/E of 862.89, reflecting limited profitability relative to valuation. This sale does not deviate from the CFO's established pattern at this ticker.

NTNX director de Groen Max Pieter sold 5,480,467 shares at $76.81 on 2025-06-05; reduces stake by -50.6% to 5,355,285 shares; stock trading at $75.44 (-9.2% from 52-week high)

Director de Groen Max Pieter divested exactly half his NTNX shareholding, reducing his position from 10,835,752 to 5,355,285 shares through a single open-market sale of 5,480,467 shares valued at $420,954,670.27. The sale occurred near the company's 52-week high of $83.07, with the stock having advanced 13.5% over the prior 90 days, though it has since declined 9.2% from peak. His prior NTNX sale on 2025-03-04 proved poorly timed, with the stock rising 3.4% in the subsequent 90 days; his cross-ticker track record shows 0 of 1 well-timed sells at the 90-day mark with an average post-sell 90-day return of +3.4%. The company trades at an extreme P/E of 838.22, generating $639.0M in quarterly revenue and $63.4M quarterly net income, though full-year results were negative. The magnitude of this divestiture—liquidating 50.6% of holdings in a single transaction—represents material capital redeployment by a director at a valuation inflection point.

Director GOMO sold 15,000 NTNX shares at $75.10; holdings decline 22.7% to 51.2K shares.

Director Steven J. Gomo sold 15,000 shares (15.0K shares) of Nutanix at $75.10 on 2025-05-30, reducing his stake by 22.7% from 66.2K to 51.2K shares. At NTNX specifically, his prior two sales (2024-09-10 and 2024-03-01) produced mixed results: one returned +8.8% over 90 days while the other declined -12.1%, yielding a 50% well-timed rate at this ticker. The current stock price of $77.72 sits 7.1% above the 30-day average and -6.4% from the 52-week high of $83.07, positioned in the upper range of the 52-week trading band. Nutanix remains unprofitable on a full-year basis despite 15.4% annual revenue growth and a $639.0M latest-quarter revenue, with a notably elevated P/E of 863.56 driven by near-breakeven net income of $63.4M against a $20.8B market cap.

NTNX CEO Ramaswami sells 61.1K shares at $79.00 (−10.9% of holdings); stock now $81.83, near 52-week high.

President and CEO Rajiv Ramaswami sold 61,057 shares of Nutanix for $4,823,503.00 on 2025-05-13, reducing his holdings to 497,309 shares (497.3K shares). The sale occurred at $79.00 per share, which was 3.46% below the current price of $81.83 and 4.05% below the 52-week high of $82.40. In the same-ticker history at NTNX, Ramaswami's 4 prior measurable sells (2024–early 2025) all resulted in positive 90-day returns (ranging from +3.5% to +9.5%), meaning the stock rose after each sale; 0 of 4 prior sales were well-timed at the 90-day mark. His cross-ticker track record shows 15 prior sells with a 14.29% well-timed rate, slightly above random. The company posted revenue of $654,721,000.00 and net income of $56,427,000.00 in the latest quarter, with annual revenue growth of +15.4%, but was unprofitable over its most recent full fiscal year. Context includes a sharp 30-day price surge of +35.5% preceding the sale, suggesting the transaction occurred near a local peak relative to the recent momentum, though the stock remains within its 52-week range.

CEO Rajiv Ramaswami sold 7,740 shares of NTNX at $75.00 for $580,500; holds 558,366 shares post-transaction.

Ramaswami sold 7,740 shares (1.4% of pre-transaction holdings) at $75.00 on 2025-03-24, just 26 basis points below the current price of $74.92 and only 3.2% below the 52-week high of $77.44. His prior five trades at NTNX have not exhibited well-timed selling: 0 of 4 measurable prior sales showed negative 90-day returns, meaning the stock rose after he sold each time. At the cross-ticker level, his track record shows an average 90-day return of +19.0% following sells, with a well-timed rate of 15.38%, indicating his prior sales have generally been poorly timed relative to subsequent price movements. The company reported quarterly revenue of $654,721,000 and net income of $56,427,000, while full-year net income was negative; annual revenue growth was +15.4%, but the company is operating with the weight of prior-year losses. The sale occurs in a context where the stock is up 16.2% over 90 days, suggesting a near-term bullish momentum that may contextualize this particular exit.

Director David Humphrey sold 5,500,000 shares of NTNX for $409.8M on 2025-03-04, reducing holdings by -99.3%.

Director David Humphrey executed a substantial divestiture of 5,500,000 shares at $74.51, bringing his post-transaction holdings down to 40,746 shares—a -99.3% reduction in position. The sale occurred at a price 4.4% above the current price of $71.36 and near the 52-week high of $77.44, during a period when the stock is up 5.3% over 90 days. The transaction's magnitude ($409,800,000.00) is significant relative to the company's market cap of $19,029,033,859.20. Context matters: NTNX reported positive net income of $56,427,000.00 in its latest quarter and revenue growth of +15.4% year-over-year, yet the company was unprofitable over its most recent full fiscal year, suggesting earnings volatility. The near-complete liquidation of a director's position warrants investor attention to whether this reflects personal liquidity needs, confidence constraints, or changing circumstances at the firm.

Director de Groen sells 5,500,000 shares of NTNX for $409.8M at $74.51, reducing stake by 33.4%

de Groen Max Pieter (Director) executed a substantial sale of 5,500,000 shares at $74.51 on 2025-03-04, generating $409,805,000.00 in proceeds and reducing his holdings from 16,460,935 to 10,960,935 shares, a net reduction of 33.4%. The sale occurred at a price $2.59 below the current market price of $77.10, and within the 52-week range of $46.00–$77.44. Nutanix reported latest-quarter revenue of $590,956,000.00 with net income of $29,926,000.00, alongside positive revenue growth of +15.4% year-over-year, though the company remains unprofitable on a full-year basis. The director's significant reduction in ownership stake occurs in a context of near-52-week-high valuation and strong recent share appreciation (30-day change: +12.1%; 90-day change: +13.0%), warranting investor scrutiny of the scale and magnitude of this holding reduction.